Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionAvoro Capital Advisors LLC
Latest Disclosed Ownership15,025,000 shares
Ownership 4.87%
Avoro Capital Advisors LLC ownership in FOLD / Amicus Therapeutics, Inc.

2025-11-14 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,025,000 shares of Amicus Therapeutics, Inc. (US:FOLD). This represents 4.87 percent ownership of the company. In their previous filing dated 2025-05-15 , Avoro Capital Advisors LLC had reported owning 20,500,000 shares, indicating a decrease of -26.71 percent.

Avoro Capital Advisors LLC has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-11-14 2025-11-14 13G/A 20,500,000 15,025,000 -26.71 4.87 -27.31
2025-05-15 2025-05-15 13G/A 23,175,000 20,500,000 -11.54 6.70 -14.10
2024-11-14 2024-11-14 13G/A 27,400,000 23,175,000 -15.42 7.80 -16.13
2024-02-14 2024-02-14 13G/A 26,800,000 27,400,000 2.24 9.30 -2.11
2023-02-14 2023-02-14 13G/A 18,500,000 26,800,000 44.86 9.50 43.94
2022-02-11 2022-02-11 13G 11,200,000 18,500,000 65.18 6.60 50.00
2020-02-14 2020-02-14 13G/A 10,125,000 11,200,000 10.62 4.40 -16.98
2019-02-14 2019-02-14 13G/A 8,763,122 10,125,000 15.54 5.30 0.00
2018-02-12 2018-02-12 13G 8,763,122 5.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-03-13 2025-12-31 13F/A-1 AMICUS THERAPEUTICS Common 03152W109 0 -100.00 0
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS Common 03152W109 0 -100.00 0
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS Common 03152W109 15,025,000 -2,975,000 -16.53 118,397 14.79 1.5304
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS Common 03152W109 18,000,000 -2,500,000 -12.20 103,140 -38.34 1.8062
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS Common 03152W109 20,500,000 -2,675,000 -11.54 167,280 -23.37 2.6111
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS Common 03152W109 23,175,000 0 0.00 218,308 -11.80 3.0878
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS Common 03152W109 23,175,000 -4,225,000 -15.42 247,509 -8.94 3.6090
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS Common 03152W109 27,400,000 0 0.00 271,808 -15.79 3.6201
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS Common 03152W109 27,400,000 0 0.00 322,772 -16.98 3.7648
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS Common 03152W109 27,400,000 0 0.00 388,806 16.69 5.3704
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS Common 03152W109 27,400,000 0 0.00 333,184 -3.18 5.1969
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS Common 03152W109 27,400,000 100,000 0.37 344,144 13.67 4.6688
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS Common 03152W109 27,300,000 500,000 1.87 302,757 -7.48 4.4885
2023-02-14 2022-12-31 13F AMICUS THERAPEUTICS Common 03152W109 26,800,000 0 0.00 327,228 16.95 4.8902
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS Common 03152W109 26,800,000 0 0.00 279,792 -2.79 5.1690
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS Common 03152W109 26,800,000 6,300,000 30.73 287,832 48.26 5.6877
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS Common 03152W109 20,500,000 2,000,000 10.81 194,135 -9.14 3.5442
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS Common 03152W109 18,500,000 820,727 4.64 213,675 26.56 3.6365
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS Common 03152W109 17,679,273 5,229,273 42.00 168,837 40.68 2.6521
2021-08-16 2021-06-30 13F AMICUS THERAPEUTICS Common 03152W109 12,450,000 200,000 1.63 120,018 -0.84 2.0878
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS Common 03152W109 12,250,000 3,250,000 36.11 121,030 -41.76 2.0902
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS Common 03152W109 9,000,000 -1,850,000 -17.05 207,810 35.64 3.5789
2020-11-16 2020-09-30 13F AMICUS THERAPEUTICS Common 03152W109 10,850,000 -150,000 -1.36 153,202 -7.64 2.1766
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS Common 03152W109 11,000,000 50,000 0.46 165,880 63.95 3.2795
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS Common 03152W109 10,950,000 -250,000 -2.23 101,178 -7.25 3.4151
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS Common 03152W109 11,200,000 100,000 0.90 109,088 22.54 3.2031
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS Common 03152W109 11,100,000 1,100,000 11.00 89,022 -28.67 3.7135
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS Common 03152W109 10,000,000 500,000 5.26 124,800 -3.41 4.3142
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS Common 03152W109 9,500,000 -625,000 -6.17 129,200 33.20 5.5868
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS Common 03152W109 10,125,000 791,868 8.48 96,998 -14.04 5.7985
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS Common 03152W109 9,333,132 -36,018 -0.38 112,838 -22.90 5.1816
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS Common 03152W109 9,369,150 -136,297 -1.43 146,346 2.37 5.6337
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS Common 03152W109 9,505,447 2,242,325 30.87 142,962 36.78 6.8269
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS Common 03152W109 7,263,122 826,000 12.83 104,516 7.67 6.7744
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS Common 03152W109 6,437,122 506,166 8.53 97,072 62.53 7.5292
2017-08-14 2017-06-30 13F AMICUS THERAPEUTICS Common 03152W109 5,930,956 1,083,379 22.35 59,725 72.80 7.5413
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS Common 03152W109 4,847,577 830,000 20.66 34,563 73.10 4.4152
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS Common 03152W109 4,017,577 327,720 8.88 19,967 -26.87 4.0336
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS Common 03152W109 3,689,857 -8,808 -0.24 27,305 35.21 4.7911
2016-08-15 2016-06-30 13F AMICUS THERAPEUTICS Common 03152W109 3,698,665 274,561 8.02 20,195 -30.20 4.4877
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS Common 03152W109 3,424,104 -91,507 -2.60 28,934 -15.15 10.0938
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS Common 03152W109 3,515,611 -734,588 -17.28 34,101 -42.65 11.7469
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS Common 03152W109 4,250,199 -340,000 -7.41 59,460 -8.45 15.4583
2015-08-14 2015-06-30 13F AMICUS THERAPEUTICS Common 03152W109 4,590,199 378,800 8.99 64,951 41.75 17.8871
2015-05-15 2015-03-31 13F AMICUS THERAPEUTICS Common 03152W109 4,211,399 1,387,214 49.12 45,820 95.00 17.5840
2015-02-13 2014-12-31 13F AMICUS THERAPEUTICS Common 03152W109 2,824,185 2,824,185 23,497 15.9191
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS Common Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS Common Call 2,350,100 56.67 3,760 113.27 n/a n/a n/a
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS Common Call 1,500,000 -50.00 1,763 -79.01 n/a n/a n/a
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS Common Call 3,000,000 1,100.00 8,400 1,478.95 n/a n/a n/a
2017-08-14 2017-06-30 13F AMICUS THERAPEUTICS Common Call 250,000 0.00 532 158.25 n/a n/a n/a
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS Common Call 250,000 206 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.